HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

The phytoestrogen 8-prenylnaringenin inhibits agonist-dependent activation of human platelets.

AbstractBACKGROUND:
Phytoestrogens are plant-derived polyphenolic compounds that exert beneficial effects on human health, mostly related to their estrogen mimetic activity. In particular a strong correlation between phytoestrogens intake and a lower risk of cardiovascular diseases has been reported. The flavanone 8-prenylnaringenin, extracted from hop flowers, has been identified as a novel phytoestrogen, unique with respect to estrogen receptors specificity and potency. However, to date no investigations on the 8-prenylnaringenin role in modulating platelet function have been undertaken.
METHODS:
We evaluated the effect of 8-prenylnaringenin on platelet aggregation, intracellular calcium mobilization and protein phosphorylation triggered by thrombin and collagen, and platelet adhesion and dense granule secretion triggered by collagen.
RESULTS:
8-Prenylnaringenin inhibited platelet aggregation induced by different agonists and platelet adhesion to collagen matrix. 8-Prenylnaringenin directly increased intracellular cAMP and cGMP levels and thus promoted VASP phosphorylation. However, these molecular events were not responsible for the inhibitory action of 8-prenylnaringenin on platelets. Moreover, 8-prenylnaringenin inhibited the phosphorylation of Pyk2, Akt, and ERK1/2. Finally, 8-prenylnaringenin suppressed the mobilization of calcium and the secretion of dense granules. All these effects were independent of estrogen receptors recruitment.
CONCLUSIONS:
8-Prenylnaringenin exerted anti-aggregatory and anti-adhesive effects on human platelets, independently of estrogen receptors, acting as an inhibitor of multiple proteins essential for the morphological and biochemical transformations that occur during platelet activation and aggregation.
GENERAL SIGNIFICANCE:
8-Prenylnaringenin may represent a useful tool in the therapy and prevention of vascular diseases associated with platelet aggregation, such as atherosclerosis, myocardial infarction, coronary artery disease, and thrombosis.
AuthorsClara Di Vito, Alessandra Bertoni, Michela Nalin, Sara Sampietro, Manuela Zanfa, Fabiola Sinigaglia
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1820 Issue 11 Pg. 1724-33 (Nov 2012) ISSN: 0006-3002 [Print] Netherlands
PMID22766195 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier B.V. All rights reserved.
Chemical References
  • 8-prenylnaringenin
  • Flavanones
  • Phytoestrogens
  • Cyclic AMP-Dependent Protein Kinases
  • Cyclic GMP-Dependent Protein Kinases
  • Calcium
Topics
  • Calcium (metabolism)
  • Cyclic AMP-Dependent Protein Kinases (physiology)
  • Cyclic GMP-Dependent Protein Kinases (physiology)
  • Cytoplasmic Granules (drug effects, secretion)
  • Flavanones (pharmacology)
  • Humans
  • Phosphorylation
  • Phytoestrogens (pharmacology)
  • Platelet Activation (drug effects)
  • Platelet Aggregation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: